Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Modality Therapy for Recurrent Head and Neck Carcinoma
NCT00003777Phase 2Terminated
- Sponsor
- Abramson Cancer Center
- Start
- Dec 1998
- Primary completion
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in head and neck cancer (HNC), sponsored by Abramson Cancer Center. Started Dec 1998; status: terminated.
02
Drugs
amifostine
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00003777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003777.